Advanced technologies. Our plant is compliant with Good Manufacturing Practice (GMP) standards and produces active pharmaceutical ingredients from recombinant micro organisms. This plant, together with a highly experienced R&D department, serves as the foundation for implementation of the company's strategic plans.

Sicor Biotech in its daily activities creates a balance between the well-being of its employees, customers, the society, and a healthy and safe environment.

The key of our success is the development of products for the global market. We produce formulations of recombinant biopharmaceuticals that are efficiently used to treat patients in various countries. Drug products produced by the Lithuanian scientists have been registered in the EU, Switzerland, Israel and Brazil, their ongoing registration takes part in other states such as the USA, Australia, Russia, etc.

We continuously develop new biopharmaceuticals drug products and improve the existing formulations of drug products.